2021
DOI: 10.1080/02713683.2021.1879868
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of the Effects of Intravitreal Aflibercept and Ranibizumab on Systemic Inflammatory and Cardiovascular Biomarkers in Patients with Neovascular Age-related Macular Degeneration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 33 publications
0
2
0
Order By: Relevance
“…On the other hand, we found that the biochemical parameter cholesterol was reduced over time, being this reduction bigger in the poor responders group, probably due to having a bigger population on statin treatment. Despite non-responders being on more statins, they have a similar basal cholesterol value between both groups and the lowering of cholesterol occurs in both groups, so it could be a good candidate to monitor response as this reduction was also observed other studies, although it did not reach significance [35,36]. These studies also measured lipoproteins such as HDL and LDL.…”
Section: Discussionmentioning
confidence: 95%
See 1 more Smart Citation
“…On the other hand, we found that the biochemical parameter cholesterol was reduced over time, being this reduction bigger in the poor responders group, probably due to having a bigger population on statin treatment. Despite non-responders being on more statins, they have a similar basal cholesterol value between both groups and the lowering of cholesterol occurs in both groups, so it could be a good candidate to monitor response as this reduction was also observed other studies, although it did not reach significance [35,36]. These studies also measured lipoproteins such as HDL and LDL.…”
Section: Discussionmentioning
confidence: 95%
“…We did not find similar results with other studies that used ranibizumab as anti-VEGF treatment [ 45 ]. Erdem et al found significance in the reduction of these parameters when intravitreal aflibercept was used, but not when intravitreal ranibizumab was administered [ 36 ]. Moreover, we also found that poor responders had a significant change over time compared with good responders, but, since all fluctuations of these parameters remained within the stablished therapeutic range after the loading phase, it does not seem likely that these differences would have any clinical effect.…”
Section: Discussionmentioning
confidence: 99%
“…CAR serves as a valuable clinical indicator, offering insights into both the inflammatory response and nutritional status in patients with a comprehensive range of conditions. It has been widely employed to forecast the prognosis of various infectious diseases due to the convenience of obtaining test results [27][28][29][30][31][32][33][34][35]. CAR encompass two key components: CRP and ALB.…”
Section: Discussionmentioning
confidence: 99%